Ibandronate Sodium

CAS 138844-81-2 5 FDA-DMF suppliersSmall Molecule

Overview

Ibandronate Sodium is a bisphosphonate class drug used to prevent and treat osteoporosis in postmenopausal women. It works by inhibiting osteoclast-mediated bone resorption, thus increasing bone mineral density.

API suppliers (6)

Suppliers of Ibandronate Sodium backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • Apotex Inc.Canada1 active DMF
  • Apotex Inc.Canada1 active DMF
  • ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
  • ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
  • ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
  • Taro Pharmaceutical Industries Ltd.Israel

Therapeutic areas

OsteoporosisBone Disorders

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.